The capital infusion, which does not involve any sale of shares by the listed gaming company, will dilute the parent firm’s stake in Nodwin Gaming below 50%, resulting in the latter’s reclassification from a subsidiary to an associate company, according to a stock exchange filing.
Nazara Technologies will nonetheless…








